Helen Torley's Net Worth
Helen Torley's net worth is estimated to be at least $11,867,794.29 as of 06/27/2025. CoreStreet's estimation of Helen Torley's net worth is based on their sale of stock and current holding of stock.
Helen Torley is CEO at Halozyme Therapeutics Inc. They have executed at least 20 trades of stock as per SEC Form 4 filings. Their most recent trade was for 20,000 units of HALO stock on 06/24/2025. Their biggest sale was on 08/12/2013 when they sold 9,311 units of Amgen Inc stock for $1,181,472.79. They typically trade 3 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $11,867,794.29
Most recent insider trade:
- June 24, 2025
Helen Torley's Insider Trading History
Halozyme Therapeutics Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
June 24, 2025 | CEO | 20,000 | $53.73 | Sell | $1,074,600.00 |
June 20, 2025 | CEO | 20,000 | $52.96 | Sell | $1,059,200.00 |
Oct. 9, 2024 | CEO | 10,000 | $52.58 | Sell | $525,800.00 |
Sept. 25, 2024 | CEO | 10,000 | $56.34 | Sell | $563,400.00 |
Sept. 12, 2024 | CEO | 10,000 | $59.20 | Sell | $592,000.00 |
Sept. 10, 2024 | CEO | 10,000 | $59.09 | Sell | $590,900.00 |
Aug. 31, 2023 | CEO | 10,000 | $42.82 | Sell | $428,200.00 |
Aug. 29, 2023 | CEO | 10,000 | $42.40 | Sell | $424,000.00 |
Aug. 17, 2023 | CEO | 10,000 | $43.18 | Sell | $431,800.00 |
July 26, 2023 | CEO | 10,000 | $42.69 | Sell | $426,900.00 |
March 9, 2023 | CEO | 10,000 | $42.73 | Sell | $427,300.00 |
March 7, 2023 | CEO | 10,000 | $45.47 | Sell | $454,700.00 |
Feb. 16, 2023 | CEO | 11,061 | $49.26 | Sell | $544,864.86 |
Feb. 8, 2023 | CEO | 10,000 | $51.36 | Sell | $513,600.00 |
Jan. 19, 2023 | CEO | 10,000 | $52.41 | Sell | $524,100.00 |
Dec. 15, 2022 | CEO | 10,000 | $57.37 | Sell | $573,700.00 |
Nov. 17, 2022 | CEO | 10,000 | $52.15 | Sell | $521,500.00 |
Amgen Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
Aug. 12, 2013 | EVP | 9,311 | $126.89 | Sell | $1,181,472.79 |
May 13, 2013 | EVP | 8,250 | $98.13 | Sell | $809,572.50 |
Oct. 4, 2012 | EVP | 2,314 | $86.51 | Sell | $200,184.14 |